Invesco
RGLS

Invesco’s Regulus Therapeutics RGLS Stock Holding History

Invesco’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,460
Closed -$51.6K – 3854
2025
Q1 		$51.6K Sell
29,460
-788
-3% -$1.04K ﹤0.01% 3694
2024
Q4 		$47.8K Buy
30,248
+1,995
+7% +$3.06K ﹤0.01% 3692
2024
Q3 		$44.4K Sell
28,253
-808
-3% -$1.34K ﹤0.01% 3697
2024
Q2 		$51.9K Buy
+29,061
New +$67.4K ﹤0.01% 3819
2018
Q4 		– Sell
-150
Closed -$4K – 3863
2018
Q3 		$4K Sell
150
-19
-11% -$626 ﹤0.01% 3876
2018
Q2 		$13K Buy
+169
New +$14K ﹤0.01% 3845
2015
Q3 		– Sell
-4
Closed -$6K – 3953
2015
Q2 		$6K Sell
4
-708
-99% -$1.14M ﹤0.01% 4129
2015
Q1 		$1.45M Buy
+712
New +$1.55M ﹤0.01% 2819

Other funds holding RGLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Invesco's RGLS Position: Q2 2025 in Review

Invesco sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 29,460 shares — an estimated $51.6K sold.

Invesco first reported a position in RGLS in Q1 2015 and held it in 8 quarters. The position peaked at $1.45M in Q1 2015. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

  • Invesco reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Invesco sold 29,460 Regulus Therapeutics shares in Q2 2025, an estimated $51.6K.
  • Invesco first reported a position in Regulus Therapeutics in Q1 2015 and held it in 8 quarters.
  • Invesco's Regulus Therapeutics position peaked at $1.45M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.